BIOLASE (BIOL) Dividend: History, Dates & Yield - 2024
Tags:Dividend History
BIOLASE announced a quarterly dividend of $0.01 per ordinary share, payable on 2005-07-12, with an ex-dividend date of 2005-06-24. BIOLASE typically pays dividends three times a year.
Find details on BIOLASE's dividend performance with a comprehensive history of past and upcoming payments.
| Ex-Div date | Dividend amount | Dividend type | Pay date |
|---|---|---|---|
| 2005-06-24 | $0.01 | quarterly | 2005-07-12 |
| 2005-04-21 | $0.01 | quarterly | 2005-05-09 |
| 2005-02-08 | $0.01 | quarterly | 2005-02-24 |
| 2004-12-13 | $0.01 | quarterly | 2004-12-29 |
| 2004-10-08 | $0.01 | quarterly | 2004-10-27 |
| 2004-08-12 | $0.01 | quarterly | 2004-08-30 |
Dividend Increase
By comparing BIOLASE's dividend growth to other companies, investors can gain insight into how consistent its dividend strategy is and what that means for future payouts. However, dividend growth is just one factor to consider. Investors should also evaluate other metrics, such as earnings growth, payout ratio, and overall financial health, to get a full picture of Walmart's dividend sustainability and potential.
Dividend Yield
BIOLASE's current trailing twelve-month (TTM) dividend yield is nan%.
| Company | Dividend Yield | Annual Dividend | Stock Price |
|---|---|---|---|
| BIOLASE (BIOL) | NaN% | $0.03 | $0.02 |
| null (null) | null% | 0 | 0 |
| null (null) | null% | 0 | 0 |
Dividend Yield Calculator
Interested in purchasing BIOLASE stock? Use our calculator to estimate your expected dividend yield and see how Walmart's consistent payouts could contribute to your long-term investment goals. Understanding your potential returns can help you make an informed decision.
Payout Ratio
BIOLASE has a payout ratio of 0.00%. In comparison, Bone Biologics has a payout ratio of 0.00%, while Bluejay Diagnostics's payout ratio is 0.00%.
It's important to note that the payout ratio is just one of many metrics investors use to assess a company's dividend sustainability and growth potential. It should be considered alongside other financial indicators such as earnings, cash flow, and debt levels to gain a complete picture of the company's financial health.
About BIOLASE
- Global presence Company has operations in multiple countries across continents
- Key Segments Diversified product lines in sectors such as technology, healthcare, and consumer goods
- Products/Services Offers a range of innovative products and services catering to various industries
- Financial stability Demonstrates consistent growth and profitability over the years, with strong balance sheet and cash flow
- Dividend track record Company has a history of paying regular dividends to shareholders, reflecting stability and commitment to investors
- Future outlook Strong growth prospects and strategic initiatives in place to drive longterm value for dividend investors
Frequently Asked Question
1. Growth opportunities: Companies, especially in fast-growing industries like technology, reinvest earnings into expansion, R&D, or acquisitions to fuel future growth and increase company value.
2. Tax implications: Not paying dividends can reduce the tax burden on shareholders, who may prefer to defer taxes until selling shares and realizing capital gains.
3. Investor preferences: Some investors prefer companies to reinvest profits for higher long-term returns, particularly those seeking capital appreciation over income.
4. Capital allocation priorities: Companies may allocate cash to pay down debt, fund share buybacks, or invest in projects with higher returns than dividends.
5. Market expectations: In certain sectors, like technology, reinvesting profits for growth and innovation is often prioritized over distributing dividends to shareholders.
Place an order: Use the brokerage's trading platform to place an order to buy BIOLASE stock.
Remember that buying stocks involves risk, and it's important to carefully consider your investment goals, risk tolerance, and conduct thorough research before making any investment decisions.